Theratechnologies Inc. (NASDAQ:THTX) Q3 2022 Earnings Conference Call October 13, 2022 8:30 AM ET

Company Participants

Elif McDonald - Head of Investor Relations

Paul Levesque - President and Chief Executive Officer

Philippe Dubuc - Chief Financial Officer

Christian Marsolais - Chief Medical Officer

John Leasure - Global Commercial Officer

Conference Call Participants

Andre Uddin - Research Capital

Endri Leno - National Bank

Doug Loe - Leede Jones Gable

Operator

Good morning ladies and gentlemen and thank you for standing by. Welcome to Theratechnologies' Third Quarter Fiscal Year 2022 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] I would like to remind everyone that this conference call is being recorded today, October 13, 2022 at 8:30 A.M. Eastern Time.

I will now turn the call over to Ms. Elif McDonald, Head of Investor Relations. Please go ahead, ma’am.

Elif McDonald

Thank you, operator and good morning, everyone. On the call today will be our President and Chief Executive Officer, Mr. Paul Levesque; Chief Financial Officer, Mr. Philippe Dubuc. During the Q&A session, we will be joined by Dr. Christian Marsolais, Chief Medical Officer; and Mr. John Leasure, our Global Commercial Officer.

Before we begin, I'd like to remind everyone that Theratechnologies' remarks today contains forward-looking statements regarding its current and future plan, expectations and intentions with respect to future events. Forward-looking statements are based on assumptions and there are risks that results obtained by the company will differ materially from those assumptions.

As such, the company cannot guarantee that any forward-looking statements will materialize and you are cautioned not to place undue reliance on them. We refer current and potential investors to the forward-looking information section of our management's discussion and analysis issued this morning and available on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. Forward-looking statements represent Theratechnologies' expectations as of October 13, 2022.

With that, it is my pleasure to turn the conference over to Theratechnologies' President and CEO, Paul Levesque. Paul?

Paul Levesque

Thanks, Elif. Hello, everyone. Thank you for joining us today. Before we start our review of the current reporting period, I'm proud to say that thus far fiscal 2022 has been an overwhelming success. Quantitatively, our performance to date stands at testimony to the company's hard work in transforming the business for both immediate and future growth. We have witnessed the organization come together as a team over the course of the last year, which is reflected in our numbers.